Heparins dị obere akpụ akpụ (LMWH) bụ klaasị nke ọgwụ anticoagulant ndị eji eme ihe iji gbochie ma gwọọ nsogbu nke thromboembolic.
Oke ngwa dị obosara, na-ejikọ profaịlụ nke ọgwụgwọ na ọgwụgwọ, yana ọgwụ mberede.
N'adịghị ka onye buuru ya ụzọ, Heparin, LMWH akpọwo ọrụ ọgwụ, na-adị nchebe ma na-achịkwa karịa, enwere ike ịchịkwa ya na subcutaneously ma ọ bụ intravenously.
Taa, ọtụtụ ọgbọ nke ọgwụ ndị a ka a na-egosi n'ahịa, nke a na-agbakwunye ọgwụ ọhụụ mgbe niile. Isiokwu a ga-elekwasị anya na Fraxiparin, ọnụahịa na ogo ya nke igbo mkpa nke ndị dọkịta na ndị ọrịa.
Ihe ngosi
Ihe na-arụ ọrụ nke Fraxiparin bụ calcium nadroparin, nke egosiri n'ọnọdụ ọnọdụ ndị a:
- mgbochi thrombosis na ndị ọrịa nwere profaịlụ nke ịwa ahụ;
- ọgwụgwọ ịba ọcha n'anya embolism;
- ọgwụgwọ nke thrombophlebitis nke usoro dị iche iche;
- igbochi coagulation ọbara n'oge ịba ọcha n'anya;
- na ọgwụgwọ nke nnukwu coronary syndrome (nkụchi obi).
Ọ dị mkpa iburu n'uche na a na-eji Fraxiparin mee ihe na ụlọ ọgwụ n'okpuru nlekọta nke dọkịta. Tupu oge a, a ga-eme ọtụtụ usoro mmụta na ụlọ nyocha, ọkachasị nke kọlọtọ.
Ihe ngbanwe
Enweghị ọgwụ ọ bụla kwesịrị ekwesị maka ndị ọrịa niile.
Tupu ojiji, ị ga-akpachara anya gụọ ntuziaka ma chọpụta ma ị nwere contraindications ndị a:
- mmeghachi omume nfụkasị na calcium nadroparin ma ọ bụ ihe inyeaka nke bụ akụkụ nke azịza ahụ;
- thrombocytopenia;
- ọbara ọgbụgba ma ọ bụ ihe nwere ike ibute ọrịa ya;
- ọnya ụdọ;
- afọ ime na lactation;
- okpu gbasara akwara;
- ụmụaka na-erubeghị afọ 18 (contraindication).
N'adịghị ka Heparin, nke nwere ọgwụ mgbochi ebumpụta ụwa - protamine sulfate, LMWH adịghị eme.
Mpempe mwepụta
Fraxiparin dị ka ihe ngwọta maka nchịkwa Subcutaneous ma ọ bụ nke akwara umeji. A na-eji okpu nchebe kpuchie ya n'ime sirinji eji emechi emechi nke oma.
Ngwọta maka nchịkwa subcutaneous nke Fraxiparin
A na - ejikarị subcutaneously, maka nke a na - ewepụ sirinji ahụ na akpụkpọ ahụ ma ewepu okpu ahụ. A na-eji ebe mgbochi (mpaghara eriri nwa) na-agwọ ọrịa ugboro atọ.
A na-eme mkpịsị aka anụ ahụ site na mkpịsị aka nke aka ekpe, a na-etinye agịga kpam kpam n'ọnọdụ anụ ahụ ogologo oge niile. A na-ewepụ sirinji ahụ, ọ dịghị mma maka ijiri ya.
Emeputa
Fraxiparin bu ogwu eji ere ahia sitere na ulo oru ndi America achoro Aspen.Companylọ ọrụ a anọwo n’ahịa dị ihe karịrị afọ 160, dị ka afọ 2017 si kwuo, ọ bụ n’etiti ndị isi ụwa iri na mmepụta ọgwụ, ọgwụ na akụrụngwa ụlọ ọrụ.
Companieslọ ọrụ French Sanofi-aventis na Glaxosmithkline na-ewepụta ọtụtụ ihe dị iche iche nke calcium nadroparin, dịkwa n'okpuru aha ahia Fraxiparin.
N'okwu a, ọgwụ ahụ bụ ọnya (zụta ikike imeputa site na Aspen). Na Ukraine, Nadroparin-Farmeks dị maka orire, nke ụlọ ọrụ Farmeks mepụtara.
Mbukota
Dị na sirinji ndị nwere ike iwepu 0.3, 0.4, 0.6 na 0.8 ml, iberibe 10 na otu ngwugwu.
Ogwu ogwu
0.3 ml
Ogo a dabere na ịta nke ihe dị n'ọrụ - calcium nadroparin, nke a tụrụ na nkeji mba ụwa.
1 ml nke Fraxiparin nwere 9500 IU nke ihe mejuputara.
N'ihi ya, na 0.3 ml ga-abụ 2850ME. Na ego a, egosiri ọgwụ ahụ maka ndị ọrịa na-adịkarịghị kilogram 45.
0,4 ml
Nwere 3800 IU nke kalọtarin nadroparin, egosiri maka ndị ọrịa na-eri site na kilogram 50 ruo 55.
0.6 ml
Nwere 5700ME ihe eji arụ ọrụ, dị mma maka ndị ọrịa sitere na 60 n'arọ 69 n'arọ.
Efu
Ọnụahịa nke Fraxiparin dabere na dose na onye nrụpụta. O n’enweghi ekwuputa na ogwu eji eme onu ahia dikwa oke onu karia ihe eji eme ogwu.
Ọnụahịa nke Fraxiparin, dabere na usoro onunu ogwu:
| Dose na ml | Ọnụ ego na Russia na rubles maka sirines iri |
| 0,3 | 2016 ― 2742 |
| 0,4 | 2670 ― 3290 |
| 0,6 | 3321 ― 3950 |
| 0,8 | 4910 ― 5036 |
Ahịa bụ nkezi, ewepụtara maka afọ 2017. Nwere ike ịdị iche site na mpaghara na ahịa ọgwụ.
Vidiyo ndị metụtara
Banyere usoro nke thrombophlebitis na ọrịa shuga na vidiyo:
Ya mere, Fraxiparin bụ ọgwụ dị oke mkpa maka ọgwụgwọ na mgbochi nke thrombosis. N'ime uru dị iche iche dị iche iche, usoro ọgwụgwọ dịnụ, nchekwa na ọnụ ahịa ezi uche dị na ya.
